Skip to content

Medical Devices Regulations

SOR/98-282

In forceCurrent to September 30, 2026 HistoryRegistered on May 7, 1998Made under: Food and Drugs Act

Loading…

Part 1 — General

ss. 8 to 46

Application

 This Part applies to medical devices that are not subject to Part 2 or 3.

Manufacturer’s Obligations

  •  (1) A manufacturer shall ensure that the medical device meets the applicable requirements of sections 10 to 20.

  • (2) A manufacturer shall keep objective evidence to establish that the medical device meets those requirements.

  • SOR/2015-193, s. 7
.

Safety and Effectiveness Requirements

 A medical device shall be designed and manufactured to be safe, and to this end the manufacturer shall, in particular, take reasonable measures to

  • (a) identify the risks inherent in the device;

  • (b) if the risks can be eliminated, eliminate them;

  • (c) if the risks cannot be eliminated,

    • (i) reduce the risks to the extent possible,

    • (ii) provide for protection appropriate to those risks, including the provision of alarms, and

    • (iii) provide, with the device, information relative to the risks that remain; and

  • (d) minimize the hazard from potential failures during the projected useful life of the device.

  • SOR/2022-197, s. 12(F)
.
  •  (1) A medical device other than a decorative contact lens shall not, when used for the medical conditions, purposes or uses for which it is manufactured, sold or represented, adversely affect the health or safety of a patient, user or other person, except to the extent that a possible adverse effect of the device constitutes an acceptable risk when weighed against the benefits to the patient and the risk is compatible with a high level of protection of health and safety.

  • (2) A decorative contact lens shall not adversely affect the health or safety of a user, except to the extent that a possible adverse effect of the device constitutes a risk that is compatible with a high level of protection of health and safety.

  • SOR/2015-193, s. 2
.
  •  (1) A medical device other than a decorative contact lens shall perform as intended by the manufacturer and shall be effective for the medical conditions, purposes and uses for which it is manufactured, sold or represented.

  • (2) A decorative contact lens shall perform as intended by the manufacturer.

  • SOR/2015-193, s. 2
.

 During the projected useful life of a medical device, its characteristics and performance shall not deteriorate under normal use to such a degree that the health or safety of a patient, user or other person is adversely affected.

 The characteristics and performance of a medical device shall not be adversely affected by transport or conditions of storage, taking into account the manufacturer’s instructions and information for transport and storage.

 Reasonable measures shall be taken to ensure that every material used in the manufacture of a medical device shall be compatible with every other material with which it interacts and with material that may come into contact with it in normal use, and shall not pose any undue risk to a patient, user or other person.

 The design, manufacture and packaging of a medical device shall minimize any risk to a patient, user or other person from reasonably foreseeable hazards, including

  • (a) flammability or explosion;

  • (b) presence of a contaminant or chemical or microbial residue;

  • (c) radiation;

  • (d) electrical, mechanical or thermal hazards; and

  • (e) fluid leaking from or entering into the device.

 A medical device that is to be sold in a sterile condition shall be manufactured and sterilized under appropriately controlled conditions, and the sterilization method used shall be validated.

 A medical device that is part of a system shall be compatible with every other component or part of the system with which it interacts and shall not adversely affect the performance of that system.

  • SOR/2023-247, s. 8(F)
.

 A medical device that performs a measuring function shall be designed to perform that function within tolerance limits that are appropriate for the medical conditions, purposes and uses for which the device is manufactured, sold or represented.

 If a medical device consists of or contains software, the software shall be designed to perform as intended by the manufacturer, and the performance of the software shall be validated.

Labelling Requirements

  •  (1) No person shall import or sell a medical device unless the device has a label that sets out the following information:

    • (a) the name of the device;

    • (b) the name and address of the manufacturer;

    • (c) the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;

    • (d) in the case of a Class III or IV device, the control number;

    • (e) if the contents are not readily apparent, an indication of what the package contains, expressed in terms appropriate to the device, such as the size, net weight, length, volume or number of units;

    • (f) the word “Sterile”, if the manufacturer intends the device to be sold in a sterile condition;

    • (g) the expiry date of the device, if the device has one, to be determined by the manufacturer on the basis of the component that has the shortest projected useful life;

    • (h) unless self-evident to the intended user, the medical conditions, purposes and uses for which the device is manufactured, sold or represented, as well as the performance specifications of the device if those specifications are necessary for proper use;

    • (i) the directions for use, unless directions are not required

      • (i) in the case of a decorative contact lens, for the device to be used safely, and

      • (ii) in the case of any other medical device, for the device to be used safely and effectively; and

    • (j) any special storage conditions applicable to the device.

  • (2) The information required pursuant to subsection (1) shall be expressed in a legible, permanent and prominent manner, in terms that are easily understood by the intended user.

  • SOR/2002-190, s. 2
  • SOR/2015-193, s. 3
.

 Despite section 21, any person who imports for sale a medical device that is not labelled in accordance with these Regulations shall ensure

  • (a) if that person holds an establishment licence to import the medical device, that they send prior notice of the proposed importation to the Minister or, if they do not hold such a licence, that the manufacturer of the medical device sends the prior notice; and

  • (b) before selling the medical device, that the manufacturer of the medical device has relabelled it in accordance with these Regulations within three months after the date of its importation.

  • SOR/2018-225, s. 1
.

 Any person who imports for sale a medical device that is not labelled in accordance with these Regulations shall ensure that the manufacturer of the medical device notifies the Minister in writing of the name of the person who will relabel it in Canada if it is to be relabelled on the manufacturer’s behalf.

  • SOR/2018-225, s. 1
.
  •  (1) Subject to subsection (2), if a medical device is intended to be sold to the general public, the information required by subsection 21(1) shall

    • (a) be set out on the outside of the package that contains the device; and

    • (b) be visible under normal conditions of sale.

  • (2) Where a package that contains a medical device is too small to display all the information in accordance with section 21, the directions for use shall accompany the device but need not be set out on the outside of the package or be visible under normal conditions of sale.

  •  (1) Subject to subsection (3), the information required by subsection 21(1) shall, as a minimum, be in either English or French.

  • (2) Subject to subsection (3), where the directions for use are supplied in only one official language at the time of sale, directions for use in the other official language shall be made available by the manufacturer as soon as possible at the request of the purchaser.

  • (3) In respect of a medical device to be sold to the general public, the information required by paragraphs 21(1)(a) and (e) to (j) shall, as a minimum, be in both English and French.

  • SOR/2002-190, s. 3
.

Contraceptive Devices — Advertising

  •  (1) For the purposes of subsections 3(1) and (2) of the Act and subject to section 27, a condom may be advertised and sold to the general public for the purpose of preventing the transmission of sexually transmitted diseases if the advertisement and the label of the condom claim only that the condom reduces the risk of transmitting sexually transmitted diseases.

  • (2) For the purpose of subsection 3(3) of the Act and subject to section 27, contraceptive devices, other than intrauterine devices, may be advertised to the general public by any means other than by the distribution of samples of the devices door-to-door or through the mail.

  • SOR/2002-190, s. 4
  • SOR/2007-289, s. 3
.

Class I Medical Devices

  •  (1) If the Minister believes on reasonable grounds, after reviewing a report or information brought to his or her attention, that a Class I medical device may not meet the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before the day specified in the request, an analysis or other information to enable him or her to determine whether the device meets those requirements.

  • (2) The Minister may direct the manufacturer to stop the sale of the medical device if

    • (a) the manufacturer has not complied with the request on or before the day specified in the request; or

    • (b) the Minister determines, on the basis of the information submitted, that the device does not meet the applicable requirements of sections 10 to 20.

  • (3) The Minister shall lift the direction to stop the sale if

    • (a) the Minister determines, on the basis of the information submitted, that the medical device meets the applicable requirements of sections 10 to 20;

    • (b) corrective action has been taken to ensure that the medical device meets the applicable requirements of sections 10 to 20; or

    • (c) the Minister’s determination was unfounded.

  • SOR/2015-193, s. 7
  • SOR/2020-262, s. 7
.

Class II, III and IV Medical Devices

Prohibition

 Subject to section 37, no person shall import or sell a Class II, III or IV medical device unless the manufacturer of the device holds a licence in respect of that device or, if the medical device has been subjected to a change described in section 34, an amended medical device licence.

 No person shall advertise a Class II, III or IV medical device for the purpose of sale unless

  • (a) the manufacturer of the device holds a licence in respect of that device or, if the device has been subjected to a change described in section 34, an amended medical device licence;

  • (a.1) the manufacturer of the device holds an authorization issued under section 68.12 in respect of that device or, if the device has been subjected to a change described in section 68.13, an amended authorization; or

  • (b) the advertisement is placed only in a catalogue that includes a clear and visible warning that the devices advertised in the catalogue may not have been licensed in accordance with Canadian law.

  • SOR/2023-19, s. 1
.

Medical Devices Deemed Licensed

 If a system is licensed, all of its components or parts that are manufactured by the manufacturer of the system are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.

 If a test kit is licensed, all of its reagents or articles that are manufactured by the manufacturer of the test kit are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.

 If a medical device or a medical device group is licensed and forms part of a medical device family or a medical device group family, as the case may be, all other medical devices or medical device groups in the family are deemed to have been licensed.

  •  (1) If all the medical devices that form part of a medical device group are licensed, that medical device group is deemed to have been licensed.

  • (2) If a medical device group is licensed, all the medical devices that form part of the medical device group are deemed, for the purposes of its importation, sale or advertisement, to have been licensed.

Application for a Medical Device Licence

  •  (1) An application for a medical device licence shall be submitted to the Minister by the manufacturer of the medical device in a format established by the Minister and shall contain the following:

    • (a) the name of the device;

    • (b) the class of the device;

    • (c) the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;

    • (d) the name and address of the manufacturer as it appears on the device label; and

    • (e) the name and address of the establishment where the device is being manufactured, if different from the one referred to in paragraph (d).

  • (2) An application for a Class II medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:

    • (a) a description of the medical conditions, purposes and uses for which the device is manufactured, sold or represented;

    • (b) a list of the standards complied with in the manufacture of the device to satisfy the applicable requirements of sections 10 to 20;

    • (c) an attestation by a senior official of the manufacturer that the manufacturer has objective evidence to establish that the device meets the applicable requirements of sections 10 to 20;

    • (d) a copy of the device label;

    • (e) in the case of a near patient in vitro diagnostic device, an attestation by a senior official of the manufacturer that investigational testing has been conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use; and

    • (f) a copy of the quality management system certificate certifying that the quality management system under which the device is manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, Medical devices — Quality management systems — Requirements for regulatory purposes, as amended from time to time.

  • (3) An application for a Class III medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:

    • (a) a description of the device and of the materials used in its manufacture and packaging;

    • (b) a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented;

    • (c) a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries;

    • (d) a list of the standards complied with in the design and manufacture of the device to satisfy the applicable requirements of sections 10 to 20;

    • (e) in the case of a device to be sold in a sterile condition, a description of the sterilization method used;

    • (f) a summary of all studies on which the manufacturer relies to ensure that the device meets the applicable requirements of sections 10 to 20, and the conclusions drawn from those studies by the manufacturer;

    • (g) a copy of the device label;

    • (h) in the case of a near patient in vitro diagnostic device, a summary of investigational testing conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use;

    • (i) a bibliography of all published reports dealing with the use, safety and effectiveness of the device; and

    • (j) a copy of the quality management system certificate certifying that the quality management system under which the device is designed and manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, Medical devices — Quality management systems — Requirements for regulatory purposes, as amended from time to time.

  • (4) An application for a Class IV medical device licence shall contain, in addition to the information and documents set out in subsection (1), the following:

    • (a) a description of the device and of the materials used in its manufacture and packaging;

    • (b) a description of the features of the device that permit it to be used for the medical conditions, purposes and uses for which it is manufactured, sold or represented;

    • (c) a list of the countries other than Canada where the device has been sold, the total number of units sold in those countries, and a summary of any reported problems with the device and any recalls of the device in those countries;

    • (d) a risk assessment comprising an analysis and evaluation of the risks, and the risk reduction measures adopted to satisfy the applicable requirements of sections 10 to 20;

    • (e) a quality plan setting out the specific quality practices, resources and sequence of activities relevant to the device;

    • (f) the specifications of the materials used in the manufacture and packaging of the device;

    • (g) the manufacturing process of the device;

    • (h) a list of the standards complied with in the design and manufacture of the device to satisfy the applicable requirements of sections 10 to 20;

    • (i) detailed information on all studies on which the manufacturer relies to ensure that the device meets the applicable requirements of sections 10 to 20, including

      • (i) pre-clinical and clinical studies,

      • (ii) process validation studies,

      • (iii) if appropriate, software validation studies, and

      • (iv) literature studies;

    • (j) in the case of a medical device other than an in vitro diagnostic device, manufactured from or incorporating animal or human tissue or their derivative, objective evidence of the biological safety of the device;

    • (k) in the case of a near patient in vitro diagnostic device, detailed information on investigational testing conducted on the device using human subjects representative of the intended users and under conditions similar to the conditions of use;

    • (l) a summary of the studies referred to in paragraph (i) and the conclusions drawn from those studies by the manufacturer;

    • (m) a summary of the investigational testing referred to in paragraph (k) and the conclusions drawn from that testing by the manufacturer;

    • (n) a bibliography of all published reports dealing with the use, safety and effectiveness of the device;

    • (o) a copy of the device label; and

    • (p) a copy of the quality management system certificate certifying that the quality management system under which the device is designed and manufactured meets the requirements set out in the National Standard of Canada CAN/CSA-ISO 13485, Medical devices — Quality management systems — Requirements for regulatory purposes, as amended from time to time.

  • SOR/2003-173, s. 2
  • SOR/2006-197, s. 2
  • SOR/2015-193, ss. 4, 7
  • SOR/2019-44, s. 2
  • SOR/2020-262, s. 8
.

Quality Management System Certificate

 The Minister shall recognize a person as a registrar for the purpose of issuing, renewing, suspending or cancelling quality management system certificates if the person

  • (a) has sufficient training, experience and technical knowledge in the design and manufacture of medical devices and in the effective implementation of quality management systems to determine whether a quality management system satisfies a standard referred to in paragraph 32(2)(f), (3)(j) or (4)(p); and

  • (b) conducts quality management system audits and issues, renews, suspends and cancels quality management system certificates in accordance with the applicable guidelines and practices established by the International Organization for Standardization.

  • SOR/2003-173, s. 3
  • SOR/2006-197, s. 3
  • SOR/2009-303, s. 1
.

 A quality management system certificate is valid for the period, not exceeding three years, specified in it.

  • SOR/2003-173, s. 3
  • SOR/2006-197, s. 4
.

 A registrar shall notify the Minister in writing within 15 days after suspending or cancelling a quality management system certificate.

  • SOR/2003-173, s. 3
  • SOR/2006-197, s. 4
.

 A registrar shall notify the Minister in writing within 15 days after the expiry of a quality management system certificate if the certificate has not been renewed.

  • SOR/2003-173, s. 3
  • SOR/2006-197, s. 4
.
  •  (1) Subject to subsection (2), the Minister may cease to recognize a person as a registrar if the Minister has reasonable grounds to believe that the person no longer meets the requirements of section 32.1 or fails to comply with section 32.3 or 32.4.

  • (2) Subject to section 32.6, the Minister shall not cease to recognize a person as a registrar unless

    • (a) the Minister has sent the registrar a written notice that sets out the reason for the proposed cessation of recognition, any corrective action required to be taken and the time within which it must be taken;

    • (b) if corrective action is required, the time set out in the notice has passed without the action having been taken; and

    • (c) the registrar has been given an opportunity to be heard in respect of the proposed cessation of recognition.

  • SOR/2003-173, s. 3
  • SOR/2009-303, s. 2
.
  •  (1) The Minister may cease to recognize a person as a registrar without giving the registrar an opportunity to be heard if it is necessary to do so to prevent injury to the health or safety of patients, users or other persons, by giving the registrar a notice in writing that states the reason for the cessation of recognition.

  • (2) A registrar may ask the Minister, in writing, that the cessation of recognition be reconsidered.

  • (3) The Minister shall, within 45 days after the date of receiving the request for reconsideration, provide the registrar with an opportunity to be heard.

  • SOR/2009-303, s. 2
.

 The Minister shall reinstate the recognition of a person as a registrar if the situation that gave rise to the cessation of recognition has been corrected or if the cessation of recognition was unfounded.

  • SOR/2009-303, s. 2
  • SOR/2011-322, s. 1
.

Foreign Manufacturers

  •  (1) If an application for a medical device licence is submitted by a manufacturer of a country other than Canada, the information and documents described in subsections 32(2) to (4) need not be submitted if

    • (a) the applicant is governed, in that country, by a regulatory authority that is recognized by the Minister; and

    • (b) the application is accompanied by a certificate of compliance and a supporting summary report, issued by a conformity assessment body of that country that is recognized by the Minister, which certify that the medical device meets the applicable requirements of sections 10 to 20.

  • (2) For the purposes of subsection (1), the Minister may recognize a regulatory authority and a conformity assessment body of a country other than Canada only if it has the ability to determine whether the device meets the applicable requirements of sections 10 to 20.

  • (3) The Minister shall, on request, make available to any interested persons the list of recognized regulatory authorities and conformity assessment bodies of countries other than Canada.

  • SOR/2015-193, s. 7
.

Application for a Medical Device Licence Amendment

 If the manufacturer proposes to make one or more of the following changes, the manufacturer shall submit to the Minister, in a format established by the Minister, an application for a medical device licence amendment including the information and documents set out in section 32 that are relevant to the change:

  • (a) in the case of a Class III or IV medical device, a significant change;

  • (b) a change that would affect the class of the device;

  • (c) a change in the name of the manufacturer;

  • (d) a change in the name of the device;

  • (e) a change in the identifier of the device, including the identifier of any medical device that is part of a system, test kit, medical device group, medical device family or medical device group family;

  • (f) in the case of a Class II medical device other than a decorative contact lens, a change in the medical conditions, purposes or uses for which the device is manufactured, sold or represented.

  • SOR/2015-193, s. 5
.

Additional Information and Samples

  •  (1) If the information and documents submitted in respect of an application for a medical device licence or a medical device licence amendment are insufficient to enable the Minister to determine whether a medical device meets the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before a specified day, additional information necessary for making the determination.

  • (2) In the course of examining the application, the Minister may require the applicant to provide samples of the medical device.

  • SOR/2015-193, s. 7
.

Issuance

Amended on January 1, 2026

  •  (1) If the Minister determines that a medical device in respect of which an application is submitted meets the applicable requirements of sections 10 to 20, the Minister shall

    • (a) issue to the manufacturer of the device a medical device licence, in the case of an application for a medical device licence; or

    • (b) amend the medical device licence, in the case of an application for a medical device licence amendment.

  • (2) The Minister may, at any time, impose terms and conditions on a medical device licence or amend such terms and conditions after considering

    • (a) whether there are uncertainties relating to the benefits or risks associated with the device;

    • (b) whether the requirements under the Act are sufficient for the following objectives to be met:

      • (i) maintaining the safety and effectiveness of the device,

      • (ii) optimizing the benefits and managing the risks associated with the device, and

      • (iii) identifying any changes relating to those benefits and risks and managing uncertainties related to the benefits and risks;

    • (c) whether the proposed terms and conditions may contribute to those objectives being met;

    • (d) whether compliance with the proposed terms and conditions is technically feasible; and

    • (e) whether there are less burdensome ways for those objectives to be met.

  • (3) [Repealed, SOR/2024-238, s. 41]

  • (4) [Repealed, SOR/2024-238, s. 41]

  • SOR/2015-193, s. 7
  • SOR/2024-238, s. 41
.

Lot of In Vitro Diagnostic Devices

Amended on January 1, 2026

 If the terms and conditions of a medical device licence for an in vitro diagnostic device require that tests be performed to ensure that the device continues to meet the applicable requirements set out in sections 10 to 20, no person shall sell a device from a lot of the in vitro diagnostic device unless

  • (a) the results and protocols of the tests performed on devices in the lot have been provided to the Minister; and

  • (b) the Minister determines, on the basis of the results and protocols provided that the devices in the lot continue to meet the applicable requirements set out in sections 10 to 20.

  • SOR/2015-193, s. 7
  • SOR/2024-238, s. 42
.

Refusal to Issue

  •  (1) The Minister may refuse to issue or amend a medical device licence if

    • (a) the applicant does not comply with these Regulations or any provisions of the Act relating to medical devices;

    • (b) the applicant has made a false or misleading statement in the application;

    • (c) the medical device does not comply with the labelling requirements set out in sections 21 to 23; or

    • (d) the applicant has not complied with a request for additional information or samples made pursuant to section 35 by the day specified in the request.

  • (2) The Minister shall refuse to issue or amend a medical device licence if the medical device does not meet the applicable requirements of sections 10 to 20 or if the information or samples provided pursuant to section 35 are insufficient to enable the Minister to determine whether the medical device meets those requirements.

  • (3) If the Minister refuses to issue or amend a medical device licence, the Minister shall

    • (a) notify the applicant in writing of the reasons for the refusal; and

    • (b) give the applicant an opportunity to be heard.

  • SOR/2015-193, s. 7
.

Requests by Minister

 If the Minister believes on reasonable grounds, after reviewing a report or information brought to his or her attention, that a licensed medical device may not meet the applicable requirements of sections 10 to 20, the Minister may request the manufacturer to submit, on or before the day specified in the request, samples — or an analysis or other information — to enable him or her to determine whether the device meets those requirements.

  • SOR/2015-193, s. 7
  • SOR/2020-262, s. 9
.

Suspension

  •  (1) Subject to subsection (3), the Minister may suspend a medical device licence if the Minister has reasonable grounds to believe that

    • (a) the licensee has contravened these Regulations or any provision of the Act relating to medical devices;

    • (b) the licensee has made a false or misleading statement in the application;

    • (c) the licensee has failed to comply with the terms and conditions of the licence;

    • (d) the licensee has not complied with a request made under section 39 on or before the day specified in the request;

    • (d.1) the samples — or the analysis or other information — submitted by the licensee in response to a request made under section 39 are insufficient to enable the Minister to determine whether the medical device meets the applicable requirements of sections 10 to 20;

    • (e) the medical device no longer meets the applicable requirements of sections 10 to 20; or

    • (f) on the basis of information obtained after the device was licensed, the quality management system under which the device has been designed, in the case of a Class III or IV device, or manufactured, assembled, processed, packaged, refurbished or modified, in the case of a Class II, III or IV device, is inadequate to ensure that the device meets its specifications.

  • (2) Before suspending a medical device licence, the Minister shall consider

    • (a) the licensee’s history of compliance with these Regulations and with the provisions of the Act relating to medical devices; and

    • (b) the risk that allowing the licence to continue to be in force would constitute for the health or safety of patients, users or other persons.

  • (3) Subject to section 41, the Minister shall not suspend a medical device licence until

    • (a) the Minister has sent the licensee a written notice that sets out the reason for the proposed suspension, any corrective action required to be taken and the time within which it must be taken;

    • (b) if corrective action is required, the time set out in the notice has passed without the action having been taken; and

    • (c) the licensee has been given an opportunity to be heard in respect of the suspension.

  • SOR/2006-197, s. 4
  • SOR/2015-193, s. 7
  • SOR/2020-262, s. 10
.
  •  (1) The Minister may suspend a medical device licence without giving the licensee an opportunity to be heard if it is necessary to do so to prevent injury to the health or safety of patients, users or other persons, by giving the licensee a notice in writing that states the reason for the suspension.

  • (2) A licensee may ask the Minister, in writing, that the suspension be reconsidered.

  • (3) The Minister shall, within 45 days after the date of receiving the request, provide the licensee with an opportunity to be heard.

 The Minister may suspend a medical device licence if, after he or she has, under section 21.31 of the Act, ordered the licensee to conduct an assessment of the medical device in order to provide evidence establishing that the benefits associated with the device outweigh the risks to the health or safety of patients, users or other persons,

  • (a) the licensee has not complied with the order; or

  • (b) the licensee has complied with the order but the Minister determines that the results of the assessment are not sufficient to establish that the benefits associated with the device outweigh the risks to the health or safety of patients, users or other persons.

  • SOR/2020-262, s. 11
.

 The Minister may reinstate a medical device licence if the situation giving rise to the suspension has been corrected or if the reason for the suspension was unfounded.

Obligation to Inform

Amended on June 17, 2026

  •  (1) Every manufacturer of a licensed medical device shall, annually before November 1 and in a form authorized by the Minister, furnish the Minister with a statement signed by the manufacturer or by a person authorized to sign on the manufacturer’s behalf

    • (a) confirming that all the information and documents supplied by the manufacturer with respect to the device are still correct; or

    • (b) describing any change to the information and documents supplied by the manufacturer with respect to the device, other than those to be submitted under section 34 or 43.1.

  • (2) If the manufacturer fails to comply with subsection (1), the Minister may cancel the medical device licence.

  • (3) If the holder of a medical device licence discontinues the sale of the medical device in Canada, the licensee shall inform the Minister within 30 days after the discontinuation, and the licence shall be cancelled at the time that the Minister is informed.

  • SOR/2003-173, s. 4
  • SOR/2026-96, s. 41(E)
.

Obligation to Submit Certificate

 Subject to section 34, if a new or modified quality management system certificate is issued in respect of a licensed medical device, the manufacturer of the device shall submit a copy of the certificate to the Minister within 30 days after it is issued.

  • SOR/2003-173, s. 5
  • SOR/2006-197, s. 4
.

Disclosure of Information in Respect of Clinical Studies or Investigational Testing

 In sections 43.12 and 43.13, information in respect of a clinical study or investigational testing means information in respect of a clinical study, or investigational testing, involving human subjects that is contained in an application for a Class III or IV medical device licence made under section 32 or in an application to amend such a licence made under section 34.

  • SOR/2019-63, s. 1
.
  •  (1) Information in respect of a clinical study or investigational testing that is confidential business information ceases to be confidential business information when one of the following circumstances occurs with respect to the application:

    • (a) the Minister issues a licence under paragraph 36(1)(a);

    • (b) the Minister amends a licence under paragraph 36(1)(b);

    • (c) the Minister refuses to issue a licence or amend a licence under section 38.

  • (2) Subsection (1) does not apply to information in respect of a clinical study or investigational testing that

    • (a) was not used by the manufacturer in the application to support the information referred to in paragraph 32(3)(b) or paragraph 32(4)(b); or

    • (b) describes tests, methods or assays that are used exclusively by the manufacturer.

  • SOR/2019-63, s. 1
.

 The Minister may disclose, without notifying the person to whose business or affairs the information relates or obtaining their consent, any information in respect of a clinical study or investigational testing that has ceased to be confidential business information.

  • SOR/2019-63, s. 1
.

Medical Devices to Be Sold for the Purposes of Implementing the General Council Decision

Application

 Sections 43.3 to 43.6 apply, for the purposes of implementing the General Council Decision, to a medical device in respect of which a manufacturer has applied to the Commissioner of Patents for an authorization under section 21.04 of the Patent Act.

  • SOR/2005-142, s. 2
  • SOR/2011-42, s. 1
.

Notices to Commissioner of Patents

 The Minister shall notify the manufacturer and the Commissioner of Patents for the purposes of paragraph 21.04(3)(b) of the Patent Act that the manufacturer’s medical device meets the requirements of the Act and these Regulations if

  • (a) the manufacturer holds a medical device licence in respect of the device issued in accordance with section 36;

  • (b) the Minister is satisfied that the manufacturer and the device comply with the Act and these Regulations;

  • (c) the manufacturer has submitted to the Minister a copy of the application filed by the manufacturer with the Commissioner of Patents under section 21.04 of the Patent Act;

  • (d) the manufacturer has submitted to the Minister information regarding the manner in which the mark referred to in paragraph 43.5(1)(a) is applied to all permanent components of the device; and

  • (e) the manufacturer has submitted to the Minister a sample of the label for the device that includes the information required by paragraph 43.5(1)(b).

  • SOR/2005-142, s. 2
.

 The Minister shall notify the manufacturer and the Commissioner of Patents for the purposes of paragraph 21.13(b) of the Patent Act in the event that the Minister is of the opinion that the manufacturer’s medical device referred to in section 43.2 has ceased to meet the requirements of the Act and these Regulations.

  • SOR/2005-142, s. 2
.

Marking and Labelling

  •  (1) No person shall sell a medical device referred to in section 43.2 unless

    • (a) the mark “XCL” is displayed on all permanent components of the device; and

    • (b) the label of the device displays the mark “XCL” followed by the control number referred to in paragraph 21(1)(d) and the words “FOR EXPORT UNDER THE GENERAL COUNCIL DECISION. NOT FOR SALE IN CANADA.” or “POUR EXPORTATION AUX TERMES DE LA DÉCISION DU CONSEIL GÉNÉRAL. VENTE INTERDITE AU CANADA.”.

  • (2) The information required by subsection (1) shall be expressed in a legible, permanent and prominent manner.

  • SOR/2005-142, s. 2
.

Notice to Minister

 The manufacturer of a medical device referred to in section 43.2 shall notify the Minister in writing not less than 15 days prior to commencing the manufacture of the device.

  • SOR/2005-142, s. 2
.

Establishment Licence

Prohibition

  •  (1) No person shall import or sell a medical device unless the person holds an establishment licence.

  • (2) Subsection (1) does not apply to the importation or sale of a medical device by

    • (a) a retailer;

    • (b) a health care facility;

    • (c) in the case of a Class II, III or IV medical device, the manufacturer of the medical device; or

    • (d) in the case of a Class I device, the manufacturer of the medical device, if the manufacturer imports or distributes solely through a person who holds an establishment licence.

  • (3) Any person who imports a medical device shall ensure that the person from whom they import it holds an establishment licence.

  • (4) Subsection (3) does not apply where a person imports

    • (a) in the case of a Class I medical device, from the manufacturer of that medical device if the person importing it holds an establishment licence; and

    • (b) in the case of a Class II, III or IV medical device, from the manufacturer of that medical device.

  • SOR/2018-225, s. 2
.

Application

 A person who wishes to apply for an establishment licence shall submit an application to the Minister, in a form established by the Minister, that contains the following information and documents:

  • (a) the name and address of the establishment;

  • (a.1) any other name under which the person previously conducted activities under these Regulations;

  • (b) the name, title and contact information of the representative of the establishment to contact for information concerning the application;

  • (c) a statement as to whether the activity of the establishment is importation or distribution, or both;

  • (d) the names and addresses of the manufacturers of the devices that are being imported or distributed;

  • (e) for each manufacturer, in respect of a medical device other than a decorative contact lens, the medical specialities in respect of which the device is imported or distributed;

  • (f) for each manufacturer, the classes of the devices that are being imported or distributed;

  • (g) an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of distribution records, complaint handling and recalls;

  • (h) if the establishment imports Class I medical devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of the making of reports under subsections 59(1) and (1.1);

  • (h.1) if the establishment imports Class II, III or IV medical devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place in respect of the making of reports under subsection 59(1) and the provision of information under section 61.2;

  • (i) if the establishment imports or distributes Class II, III or IV devices, an attestation by a senior official of the establishment that the establishment has documented procedures in place, where applicable, for handling, storage, delivery, installation, corrective action and servicing in respect of those devices; and

  • (j) the address of each building where the procedures described in paragraphs (g) to (i) are in place.

  • SOR/2011-82, s. 1(E)
  • SOR/2015-193, s. 6
  • SOR/2018-225, s. 3
  • SOR/2020-262, s. 12
  • SOR/2024-136, s. 7
.

Issuance

 Subject to section 47, the Minister shall issue an establishment licence if the Minister determines that the application meets the requirements of section 45.

  • SOR/2011-82, s. 2
.
Loading…